Analysts Set Sinclair Pharma PLC (SPH) Target Price at $54.00

Sinclair Pharma PLC (LON:SPH) has been assigned a consensus rating of “Buy” from the seven ratings firms that are covering the firm. One analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is GBX 54 ($0.70).

A number of analysts have issued reports on the stock. N+1 Singer reduced their target price on shares of Sinclair Pharma PLC from GBX 42 ($0.54) to GBX 37 ($0.48) and set a “buy” rating for the company in a research note on Wednesday, April 19th. Stifel Nicolaus reaffirmed a “buy” rating and set a GBX 71 ($0.92) target price on shares of Sinclair Pharma PLC in a research report on Tuesday, April 4th. Numis Securities Ltd restated a “hold” rating and issued a GBX 35 ($0.45) target price on shares of Sinclair Pharma PLC in a research note on Tuesday, April 4th. Jefferies Group LLC reiterated a “buy” rating and set a GBX 55 ($0.71) price target on shares of Sinclair Pharma PLC in a research report on Wednesday, March 22nd. Finally, Peel Hunt reiterated a “buy” rating and set a GBX 68 ($0.88) price target on shares of Sinclair Pharma PLC in a research report on Friday, February 24th.

Shares of Sinclair Pharma PLC (LON:SPH) remained flat at GBX 34.00 during midday trading on Monday. 9,259,710 shares of the company’s stock were exchanged. The stock’s market capitalization is GBX 170.75 million. The stock has a 50-day moving average price of GBX 32.99 and a 200-day moving average price of GBX 32.07. Sinclair Pharma PLC has a 52 week low of GBX 26.00 and a 52 week high of GBX 36.75.

COPYRIGHT VIOLATION NOTICE: “Analysts Set Sinclair Pharma PLC (SPH) Target Price at $54.00” was originally posted by BBNS and is the property of of BBNS. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this news story can be viewed at https://baseballnewssource.com/markets/brokerages-set-sinclair-pharma-plc-sph-target-price-at-54-00-updated-updated/677642.html.

Sinclair Pharma PLC Company Profile

Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor.

Receive News & Ratings for Sinclair Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinclair Pharma PLC and related companies with our FREE daily email newsletter.

 


Latest News

David Price and Red Sox to Meet Following Rehab Start
David Price and Red Sox to Meet Following Rehab Start
Lack of Offense Leading to Mediocrity for Boston Red Sox
Lack of Offense Leading to Mediocrity for Boston Red Sox
MLB and Facebook Announce Live Streaming for Games
MLB and Facebook Announce Live Streaming for Games
Can Anyway Stop the Houston Astros?
Can Anyway Stop the Houston Astros?
Kevin Pillar Turns from Defense to Offense
Kevin Pillar Turns from Defense to Offense
Chris Iannetta Hit in Face with 93mph Fastball
Chris Iannetta Hit in Face with 93mph Fastball


Leave a Reply

 
© 2006-2017 BBNS.